Veracyte (VCYT) Change in Receivables (2012 - 2026)

Veracyte has reported Change in Receivables for 15 years, with the latest figure at $4.2 million in Q2 2026.

• Change in Receivables for Q2 2026 came in at $4.2 million, up 250.25% year-over-year; the trailing twelve-month figure through Jun 2026 was $6.2 million (up 922.26% YoY), and the FY2025 annual result was $708000.0, down 88.95% from the prior year.
• Change in Receivables declined to $4.2 million in Q2 2026, from $5.6 million in the prior quarter.
• Over five years, Change in Receivables peaked at $7.1 million in Q1 2025 and troughed at -$3.2 million in Q4 2025.
• A 5-year average of $969444.4 and a median of $451000.0 in 2022 frame the typical range for Change in Receivables.
• The largest YoY upside for Change in Receivables was 448.92% in 2023 against a maximum downside of 383.72% in 2023.
• A 5-year view of Change in Receivables shows it stood at $139000.0 in 2022, then surged by 448.92% to $763000.0 in 2023, then tumbled by 360.94% to -$2.0 million in 2024, then plunged by 58.21% to -$3.2 million in 2025, then soared by 232.13% to $4.2 million in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $4.2 million in Q2 2026, $5.6 million in Q1 2026, and -$3.2 million in Q4 2025.